NBIX
#636
Neurocrine Biosciences, Inc. - Common Stock
174.1 0 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.70%
Monthly Change
+8.89%
6 month change
+28.73%
Year Change
+20.07%
Previous Close
177.1 1
Open
174.1 0
Low
174.1 0
High
174.1 0
Volume
110
Financials
- Market Capitalization 17.51 B
- Employee 2 000
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
20.27
Price to sales ratio
4.35
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 505 |  TAK Takeda Pharmaceutical Company Limited American Depositary Share | 16.49 USD | -0.42% | -2.48% | +3.84% | +16.25% | 25.69 B USD | ||
| 613 |  VTRS Viatris Inc. - Common Stock | 16.39 USD | +0.74% | -3.36% | -1.27% | +58.36% | 19.09 B USD | ||
| 788 |  ELAN Elanco Animal Health Incorporated Common Stock | 25.15 USD | +1.33% | -0.20% | +1.70% | +12.30% | 12.56 B USD | ||
| 876 |  RDY Dr. Reddy's Laboratories Ltd | 12.92 USD | -2.12% | -9.84% | -3.51% | -11.93% | 10.78 B USD |
Frequently asked questions about Neurocrine Biosciences, Inc. - Common Stock
What is the Neurocrine Biosciences, Inc. - Common Stock stock price today?
The current price of Neurocrine Biosciences, Inc. - Common Stock (NBIX) is 174.1. Over the past 24 hours, the stock has changed by -1.70%. Follow the NBIX chart for real-time price dynamics.
What is the stock ticker of Neurocrine Biosciences, Inc. - Common Stock?
Neurocrine Biosciences, Inc. - Common Stock trades under the ticker NBIX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neurocrine Biosciences, Inc. - Common Stock stock going up?
NBIX has changed by -1.13% over the last week, +8.89% over the last month, and +20.07% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Neurocrine Biosciences, Inc. - Common Stock net income for the last quarter?
Neurocrine Biosciences, Inc. - Common Stock reported net income of 197.9 M for the last quarter. The previous quarter showed 153.7 M, which means net income changed by +28.76%.
How many employees does Neurocrine Biosciences, Inc. - Common Stock have?
As of the latest available data, Neurocrine Biosciences, Inc. - Common Stock has 2 000 employees. Workforce size can provide additional context about the company's scale and operations.
What is Neurocrine Biosciences, Inc. - Common Stock EBITDA?
Neurocrine Biosciences, Inc. - Common Stock EBITDA is 199.4 M, and its EBITDA margin is 24.48%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Neurocrine Biosciences, Inc. - Common Stock stock?
You can buy Neurocrine Biosciences, Inc. - Common Stock (NBIX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neurocrine Biosciences, Inc. - Common Stock stock?
Investing in Neurocrine Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NBIX chart and related analysis on metatrader.com as part of your research.